Update Your Profile Member Spotlights Refer a Member: IASP Champions Join a Special Interest Group (SIG) Find a Chapter Join Now
PAIN PAIN Reports Pain Research Forum Papers of the Week Webinars and Podcasts Events
Online Learning - PERC Webinars & Podcasts Curricula Graduate Opportunities Events
RELIEF News Resources for Living with Pain Global Alliance of Partners in Pain Advocacy (GAPPA) Events
Support IASP Sponsor an Event Become a Partner
< BACK TO ARCHIVE
POW ARCHIVE WEEK: Papers: 6 May 2023 - 12 May 2023
RESEARCH TYPE:Clinical, Pediatric, Psychology
STUDY TYPE:Human Studies, Neurobiology, Pharmacology/Drug Development
PAIN TYPE:Itch, Psychological/Comorbidities
DATE PUBLISHED: 2023
JOURNAL:Front Immunol
PUBMED: 37153599
Volume:14
The real-world experience of dupilumab in Chinese is limited, and the initial loading dose has not yet been deeply explored in patients aged <6 years.
